Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons

Journal of Neurophysiology

Volumn 83, Issue 6, 2000, Pages 3287-3293

  Auclair, Nathalie ^a,c   Otani, Satoru ^a   Soubrie, Philippe ^b   Crepel, Francis ^a  

^a CNRS   (France)

^b SANOFI   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; RIMONABANT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EVOKED RESPONSE; EXCITATORY POSTSYNAPTIC POTENTIAL; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SYNAPSE; SYNAPTIC TRANSMISSION;

EID: 0034044078     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.2000.83.6.3287     Document Type: Article

References (46)

1. ABOOD ME AND MARTIN BR. Neurobiology of marijuana abuse. Trends Pharmacol Sci 13: 201-206, 1992.
2. AGGLETON JP, NEAVE N, NAGLE S, AND SAHGAL A. A comparison of the effects of medial prefrontal, cingulate cortex, and cingulum bundle lesions on tests of spatial memory: evidence of a double dissociation between frontal and cingulum bundle contributions. J Neurosci 15: 7270-7281, 1995.
3. ANKRI N, LEGENDRE P, FABER D, AND KORN H. Automatic detection of spontaneous synaptic responses in central neurons. J Neurosci Methods 52: 87-100, 1994.
4. BIDAUT-RUSSELL M, DEVANE WA, AND HOWLETT AC. Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J Neurochem 55: 21-26, 1990.
5. BIENENSTOCK EL, COOPER LN, AND MUNRO PW. Theory for the development of neuron selectivity: orientation specificity and binocular interaction in visual cortex. J Neurosci 2: 32-48, 1982.
6. BOUABOULA M, PERRACHON S, MILLIGAN L, CANAT X, RINALDI-CARMONA M, PORTIER M, BARTH F, CALANDRA B, PECCEU F, LUPKER J, MAFFRAND JP, LE FUR G, AND CASELLAS P. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 272: 22330-22339, 1997.
7. CHILDERS SR AND DEADWYLER SA. Role of cyclic AMP in the actions of cannabinoid receptors. Biochem Pharmacol 52: 819-827, 1996.
8. COLLINS DR, PERTWEE RG, AND DAVIES SN. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br J Pharmacol 115: 869-870, 1995.
9. DEADWYLER SA, HAMPSON RE, BENNETT BA, EDWARDS TA, MU J, PACHECO MA, WARD SJ, AND CHILDERS SR. Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels 1: 121-134, 1993.
10. DEVANE W, DYSARZ F, JOHNSON M, MELVIN L, AND HOWLETT A. Determination and characterisation of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605-613, 1988.
11. EICHENBAUM H, CLEGG RA, AND FEELEY A. Reexamination of functional subdivisions of the rodent prefrontal cortex. Exp Neurol 79: 434-451, 1983.
12. GALIEGUE S, MARY S, MARCHAND J, DUSSOSSOY D, CARRIERE D, CARAYON P, BOUABOULA M, SHIRE D, LE FUR G, AND CASELLAS P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232: 54-61, 1995.
13. GIFFORD AN AND ASHBY CR JR. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J Pharmacol Exp Ther 277: 1431-1436, 1996.
14. GIFFORD AN, SAMIIAN L, GATLEY SJ, AND ASHBY CR JR. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices. Eur J Pharmacol 324: 187-192, 1997.
15. GIUFFRIDA A, PARSONS LH, KERR TM, RODRIGUEZ DE FONSECA F, NAVARRO M, AND PIOMELLI D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nature Neurosci 2: 358-363, 1999.
16. HERKENHAM M, LYNN A, JOHNSON M, MELVIN L, DE COSTA B, AND RICE K. Characterisation and localisation of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11: 563-583, 1991.
17. HERKENHAM M, LYNN AB, LITTLE MD, JOHNSON MR, MELVIN LS, DE COSTA BR, AND RICE KC. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932-1936, 1990.
18. HIRSCH JC AND CREPEL F. Use-dependent changes in synaptic eficacy in rat prefrontal neurons in vitro. J Physiol (Lond) 427: 31-49, 1990.
19. JABER M, ROBINSON SW, MISSALE C, AND CARON MG. Dopamine receptors and brain function. Neuropharmacology 35: 1503-1519, 1996.
20. JENTSCH JD, ANDRUSIAK E, TRAN A, BOWERS MB JR, AND ROTH RH. Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology 16: 426-432, 1997.
21. JENTSCH JD, WISE A, KATZ Z, AND ROTH RH. Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex. Synapse 28: 21-26, 1998.
22. LANDSMAN RS, BURKEY TH, CONSROE P, ROESKE WR, AND YAMAMURA HI. SR141716A is an inverse agonist at the human cannabinoid CB 1 receptor. Eur J Pharmacol 334: R1-R2, 1997.
23. LAW-THO D, DESCE JM, AND CREPEL F. Dopamine favours the emergence of long-term depression versus long term potentiation in slices of rat prefontal cortex. Neurosci Lett 188: 125-128, 1995.
24. LEVENES C, DANIEL H, SOUBRIE P, AND CREPEL F. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J Physiol (Lond) 510: 867-879, 1998.
25. MACKIE K, LAI Y, WENSTENBROEK R, AND MITCHELL R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in At20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15: 6552-6561, 1995.
26. MATSUDA LA, BONNER TI, AND LOLAIT SJ. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327: 535-550, 1993.
27. MILEDI R. Strontium as a substitute for calcium in the process of transmitter release at the neuromuscular junction. Nature 212: 1233-1234, 1966.
28. MUNRO S, THOMAS KL, AND ABU-SHAAR M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65, 1993.
29. NOWICKY A, TEYLER T, AND VARDARIS R. The modulation of long term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res Bull 19: 663-672, 1987.
30. OLIET S, MALENKA R, AND NICOLL R. Bidirectional control of quantal size by symaptic activity in the hippocampus. Science 271: 1241-1297, 1996.
31. OTANI S, BLOND O, DESCE JM, AND CREPEL F. Dopamine facilitates long-term depression of glutamatergic transmission in rat prefrontal cortex. Neuroscience 85: 669-676, 1998.
32. 2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Mol Pharmacol 54: 1064-1072, 1998.
33. PERTWEE RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74: 129-180, 1997.
34. RAGOZZINO ME, ADAMS S, AND KESNER RP. Differential involvement of the dorsal anterior cingulate and prelimbic-infralimbic areas of the rodent prefrontal cortex in spatial working memory. Behav Neurosci 112: 293-303, 1998.
35. RINALDI-CARMONA M, BARTH F, HÉAULME M, SHIRE D, CALANDRA B, CONGY C, MARTINEZ S, MARUANI J, NÉLIAT G, CAPUT D, FERRARA P, SOUBRIÉ P, BRELIÈRE J, AND LE FUR G. SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240-244, 1994.
36. RINALDI-CARMONA M, PIALOT F, CONGY C, REDON E, BARTH F, BACHY A, BRELIÈRE JC, SOUBRIE P, AND LE FUR G. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB 1) cannabinoid receptor antagonist, in rodent brain. Life Sci 58: 1239-1247, 1996.
37. SCHLICKER E, TIMM J, AND GOTHERT M. Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedeberg's Arch Pharmacol 354: 791-795, 1996.
38. SEAMANS JK, FLORESCO SB, AND PHILLIPS AG. Functional differences between the prelimbic and anterior cingulate regions of the rat prefrontal cortex. Behav Neurosci 109: 1063-1073, 1995.
39. SHEN M, PISER TM, SEYBOLD VS, AND THAYER SA. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16: 4322-4334, 1996.
40. STELLA N, SCHWEITZER P, AND PIOMELLI D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778, 1997.
41. STUART GJ, DODT HU, AND SAKMANN B. Patch-clamp recordings from the soma and dendrites of neurons in brain slices using infrared video microscopy. Pflügers Arch 423: 511-518, 1993.
42. SZABO B, DORNER L, PFREUNDTNER C, NORENBERG W, AND STARKE K. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85: 395-403, 1998.
43. TERRANOVA JP, MICHAUD JC, LE FUR G, AND SOUBRIE P. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn-Schmiedeberg's Arch Pharmacol 352: 576-579, 1995.
44. TERRANOVA JP, STORME JJ, LAFON N, PERIO A, RINALDI-CARMONA M, LE FUR G, AND SOUBRIE P. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology 126: 165-172, 1996.
45. TSOU K, BROWN S, SANUDO-PENA MC, MACKIE K, AND WALKER JM. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393-411, 1998.
46. WEINROTH SE, PARENTI DM, AND SIMON GL. Wasting syndrome in AIDS: pathophysiologic mechanisms and therapeutic approaches. Infect Agents Dis 4: 76-94, 1995.